Day One Biopharmaceuticals
DAWN
DAWN
45 hedge funds and large institutions have $453M invested in Day One Biopharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 8 closing their positions.
Holders
45
Holders Change
+12
Holders Change %
+36.36%
% of All Funds
0.79%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
12
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$40.6M |
2 |
2
BlackRock
New York
|
$12.4M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$19.5M |
4 |
4
Millennium Management
New York
|
$4.22M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$4.43M |